Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Director | June 18, 2020 | June 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date June 18, 2020 · Filed June 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2027-06-18 | Direct | 15,000 |
Reported balance
After 2020-06-18 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2020-06-18 · Grant · Acquired 15,000 · Balance 15,000 |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.36 · Expires 2021-01-31 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 12,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2022-08-07 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2023-02-14 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 10,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.52 · Expires 2024-02-13 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2025-02-18 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 9,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2026-02-23 | Direct | 8,100 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 8,100 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.90 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.05 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.18 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.84 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.99 · Expires 2026-11-17 | Direct | 2,250 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 2,250 F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2027-02-21 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 10,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-05-23 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 10,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2029-05-22 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 10,000 F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common StockSEC Table I · non-derivative | Direct | 20,618 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 20,618 |
| Deferred Common StockSEC Table II · derivative / convertible security | Direct | 12,652 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 12,652 F2: Each share of deferred common stock represents a right to receive one share of common stock. F3: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. F4: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 12,652 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
F2: Each share of deferred common stock represents a right to receive one share of common stock.
F3: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F4: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 12,652 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F5: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2020 Filed Jun 19, 2020 21:49 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 15,000 | $0.45 Strike: $0.45 | $6,750.00 |
DisclosureSEC source: 0001209191-20-038022 · doc4.xml · derivative · entry 19 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-18 Read SEC document |
| May 22, 2019 Filed May 30, 2019 20:24 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.51 Strike: $0.51 | $5,100.00 |
DisclosureSEC source: 0001209191-19-033429 · doc4.xml · derivative · entry 18 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 23, 2018 Filed May 25, 2018 14:43 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.82 Strike: $0.82 | $8,200.00 |
DisclosureSEC source: 0001209191-18-033337 · doc4.xml · derivative · entry 17 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-05-23 F2 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 23, 2018 Filed May 29, 2018 15:04 UTC Amendment | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.82 Strike: $0.82 | $8,200.00 |
DisclosureSEC source: 0001209191-18-033697 · doc4a.xml · derivative · entry 17 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-05-23 F2 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:30 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.68 Strike: $0.68 | $6,800.00 |
DisclosureSEC source: 0001209191-17-013435 · doc4.xml · derivative · entry 16 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-02-21 F1 · derivative.exercise_price: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $0.99 Strike: $0.99 | $2,227.50 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 16 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $1.10 Strike: $1.10 | $2,475.00 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 15 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $1.85 Strike: $1.85 | $4,162.50 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 14 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $0.84 Strike: $0.84 | $1,890.00 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 13 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $1.18 Strike: $1.18 | $2,655.00 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 12 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $1.05 Strike: $1.05 | $2,362.50 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 11 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,250 | $0.90 Strike: $0.90 | $2,025.00 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 10 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2026-11-17 F6 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 14:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | Disposition to issuerStock Appreciation Right · Derivative | 15,750 | $1.18 Strike: $1.18 | $18,585.00 |
DisclosureSEC source: 0001209191-16-151334 · doc4.xml · derivative · entry 4 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,750 shares Expires not disclosed F5 · security: The stock appreciation rights were to become payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.exercise_price: The stock appreciation rights were to become payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99. F5 · price: The stock appreciation rights were to become payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.exercise_date: The stock appreciation rights were to become payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.expiration_date: The stock appreciation rights were to become payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99. F6 · derivative.underlying_shares: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. Read SEC document |
| September 03, 2014 Filed May 25, 2018 14:43 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 20,618 | $0.51 | $10,515.18 |
DisclosureSEC source: 0001209191-18-033337 · doc4.xml · nonDerivative · entry 1 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,618 F1 · balance_after: These shares of common stock were purchased in the open market during an open trading window for Company officers and directors. The Form 4s filed by the reporting person after September 3, 2014 and prior to the date of this Form 4 did not reflect these shares as being owned by the reporting person. Read SEC document |
| September 03, 2014 Filed May 29, 2018 15:04 UTC Amendment | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 20,618 | $0.51 | $10,515.18 |
DisclosureSEC source: 0001209191-18-033697 · doc4a.xml · nonDerivative · entry 1 Vincent George A · CIK 0001417929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,618 F1 · balance_after: These shares of common stock were purchased in the open market during an open trading window for Company officers and directors. The Form 4s filed by the reporting person after September 3, 2014 and prior to the date of this Form 4 did not reflect these shares as being owned by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.